These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 15569977)
1. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977 [TBL] [Abstract][Full Text] [Related]
2. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Umetani N; Mori T; Koyanagi K; Shinozaki M; Kim J; Giuliano AE; Hoon DS Oncogene; 2005 Jul; 24(29):4721-7. PubMed ID: 15897910 [TBL] [Abstract][Full Text] [Related]
3. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the GATA genes in lung cancer. Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625 [TBL] [Abstract][Full Text] [Related]
5. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
6. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
7. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines. Jiang Y; Tong D; Lou G; Zhang Y; Geng J Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070 [TBL] [Abstract][Full Text] [Related]
8. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Takeuchi H; Bilchik A; Saha S; Turner R; Wiese D; Tanaka M; Kuo C; Wang HJ; Hoon DS Clin Cancer Res; 2003 Apr; 9(4):1480-8. PubMed ID: 12684423 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180 [TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979 [TBL] [Abstract][Full Text] [Related]
11. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related]
12. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Lal G; Padmanabha L; Smith BJ; Nicholson RM; Howe JR; O'Dorisio MS; Domann FE Cancer; 2006 Dec; 107(12):2752-9. PubMed ID: 17103461 [TBL] [Abstract][Full Text] [Related]
13. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575 [TBL] [Abstract][Full Text] [Related]
14. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Gómez Del Pulgar T; Valdés-Mora F; Bandrés E; Pérez-Palacios R; Espina C; Cejas P; García-Cabezas MA; Nistal M; Casado E; González-Barón M; García-Foncillas J; Lacal JC Int J Oncol; 2008 Jul; 33(1):185-93. PubMed ID: 18575765 [TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989 [TBL] [Abstract][Full Text] [Related]
16. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
19. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related]
20. Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues. Kim BN; Yamamoto H; Ikeda K; Damdinsuren B; Sugita Y; Ngan CY; Fujie Y; Ogawa M; Hata T; Ikeda M; Ohue M; Sekimoto M; Monden T; Matsuura N; Monden M Int J Oncol; 2005 May; 26(5):1217-26. PubMed ID: 15809712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]